DIAGNOSTIC_TEST · Unmapped registry intervention
Breast Cancer Risk Prediction Software
Find medicine records ·
Find other trials using this name
Clinical trial
Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples
NCT05570266
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedGenetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
Breast Cancer Risk Prediction SoftwareDIAGNOSTIC_TEST
Sponsors & collaborators
Nalagenetics Pte Ltdlead sponsor
SJH Initiativescollaborator
MRCCC Siloam Hospitals Semanggicollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05570266 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.